SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-038510
Filing Date
2023-10-27
Accepted
2023-10-27 16:05:18
Documents
13
Period of Report
2023-10-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39420
2 ex10-1.htm EX-10.1 46080
  Complete submission text file 0001493152-23-038510.txt   262006

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE idxg-20231024.xsd EX-101.SCH 3018
4 XBRL LABEL FILE idxg-20231024_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE idxg-20231024_pre.xml EX-101.PRE 22361
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3141
Mailing Address WATERVIEW PLAZA, SUITE 310 2001 ROUTE 46 PARSIPPANY NJ 07054
Business Address WATERVIEW PLAZA, SUITE 310 2001 ROUTE 46 PARSIPPANY NJ 07054 412-224-6100
INTERPACE BIOSCIENCES, INC. (Filer) CIK: 0001054102 (see all company filings)

IRS No.: 222919486 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24249 | Film No.: 231355521
SIC: 3841 Surgical & Medical Instruments & Apparatus
Industrial Applications and Services